Global Drug Discovery Outsourcing Market: Overview
Drug discovery outsourcing involves a process of inventing a new medicine in the field of pharmaceuticals, biotechnology, and pharmacology. Drug discovery outsourcing is a complex, lengthy, and expensive process. Despite advanced technologies, success rate of drug discovery is very low and the time involved is relatively high. The process of drug discovery outsourcing involves target identification, target validation, high-speed screening, and lead optimization.
The final stage of drug discovery outsourcing involves obtaining a patent and running clinical trials. Most of the drugs entering clinical trials fail and become obsolete from the trials, thus leading to waste of time, cost, and efforts. Generally, small pharmaceutical companies develop new drug molecules and sell patent rights to big companies that can afford to conduct clinical trials. Many companies outsource their drug discovery outsourcing processes in order to focus on core competencies such as manufacturing, marketing, and product labeling.
Global Drug Discovery Outsourcing Market: Drivers and Restraints
Outsourcing of drug discovery Outsourcing saves time, cost, and efforts of pharmaceutical and biological companies. On the other hand, companies providing outsourcing services for drug discovery Outsourcing are established companies with developed infrastructure, a highly developed technological front, and skilled expertise. Rapidly progressing technologies, reduced approval time, increasing strategic partnerships, and research and development of biosimilars, biologics, and orphan drugs are some of the driving forces for the growth of the global drug discovery outsourcing market. Though the market scope of the drug discovery outsourcing market is vast, increase in clinical research organizations (CROs), regional expansion, niche CROs, and public-private partnerships is leading to increased competition that is restraining the growth of this market. Pharmaceutical organizations must consider a few factors in advance prior to finalizing a CRO partner like therapeutic area knowledge, plan of action, logical pool, framework, information security, IP arrangements, and cost-effectiveness. Alongside the CRO's skill, the most critical perspective pharma organizations search for in a CRO is the established reputation of effectively working in the discovery program in the therapeutic area.
Global Drug Discovery Outsourcing Market: Key Segments
The global drug discovery outsourcing market is segmented on the basis of types of services offered such as biological services, chemical services, lead identification and screening and lead optimization. Among these, biological services is the fastest growing segment showing higher growth compared to others owing to the increase in research and development budget allocations by biopharmaceutical companies.
Geographically, the global drug discovery outsourcing market is distributed into five regions namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is currently leading the drug discovery outsourcing market followed by Europe due to existence and early adoption of highly developed technologies and a supportive economy. Asia Pacific is a promising market for drug discovery outsourcing and is expected to undergo rapid growth. China and India especially are promising regions, due to the small biopharmaceutical companies outsourcing their drug discovery Outsourcing activities to CROs in China and India. Apart from nations in Asia Pacific, countries such as Russia and Ukraine are also projected to show growth progress in the future.
Global Drug Discovery Outsourcing Market: Key Players
Some of the main players in drug discovery outsourcing market are Galapagos NV, WIL Research Laboratories LLC, Albany Molecular Research, Inc. Domainex, Ltd. Evotec, Charles River Laboratories (CRL), Pharmaceutical Product Development (PPD), Wuxi Apptec, ChemPartner, Syngene, Aurigene, Jubilant, Advinus, GVK Biosciences, TCG Lifesciences, and AMRI.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.